Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
|Videos|August 25, 2020
How health care systems and providers can address cisnormativity
Halley Crissman, MD, MPH, shares her insight on the ways in which hospital systems reinforce cisnormativity and focal points to address for a more welcoming environment.
Advertisement
In a recent
Cisgender (adj): People whose gender identity and/or gender expression aligns with the gender typically associated with their sex assigned at birth.
Cisnormativity (n): The assumption that all individuals are cisgender and the ways the social world is constructed to address the needs of cisgender people and to encourage conformity with such norms.
Read the full, peer-reviewed article from Drs. Crissman and Stroumsa now: Gynecologic care considerations for transmasculine people
__
Related: Terminology for ob/gyns to use when treating transgender patients
Advertisement
Related to this article
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
Matthew Nudy, MD, on estrogen and the cardiovascular system
3
Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG
4
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
5